Pacific Biosciences of California, Inc. Stock
Stocks
PACB
US69404D1081
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
23:00:00 25/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.520 USD | +18.75% |
|
+33.33% | -18.72% |
| Market Cap | 472M 405M 379M 347M 654M 45.04B 660M 4.47B 1.74B 22.72B 1.77B 1.74B 75.26B | P/E 2026 * |
-3.45x | P/E 2027 * | -3.28x |
|---|---|---|---|---|---|
| Enterprise Value | 472M 405M 379M 347M 654M 45.04B 660M 4.47B 1.74B 22.72B 1.77B 1.74B 75.26B | EV / Sales 2026 * |
2.99x | EV / Sales 2027 * | 2.57x |
| Free-Float |
91.09% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Pacific Biosciences of California, Inc.
| 1 day | +18.75% | ||
| 1 week | +33.33% | ||
| Current month | +8.57% | ||
| 1 month | +11.76% | ||
| 3 months | +24.59% | ||
| 6 months | -6.75% | ||
| Current year | -18.72% |
| 1 week | 1.22 |  | 1.53 |
| 1 month | 1.07 | | 1.53 |
| Current year | 1.07 | | 2.73 |
| 1 year | 1.07 | | 2.73 |
| 3 years | 0.85 | | 11.96 |
| 5 years | 0.85 | | 32.55 |
| 10 years | 0.85 | | 53.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark van Oene
CEO | Chief Executive Officer | 53 | 05/08/2026 |
Jim Gibson
DFI | Director of Finance/CFO | 57 | 31/03/2025 |
Jonas Korlach
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2012 |
| Director | Title | Age | Since |
|---|---|---|---|
Bill Ericson
BRD | Director/Board Member | 67 | 01/01/2004 |
Randy Livingston
BRD | Director/Board Member | 72 | 01/01/2009 |
Marshall Mohr
BRD | Director/Board Member | 69 | 18/01/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/17/26 A | Sell | Chief Executive Officer | -26,911 | 0.0087% | ||
| 8/10/26 A | Free | Chief Executive Officer | 2,457,018 | 0.7911% | ||
| 6/3/26 A | Free | Director | 74,497 | 0.0240% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +18.75% | +33.33% | +15.15% | -84.68% | 472M | |
| -0.09% | +6.64% | +28.00% | +15.98% | 232B | |
| +0.40% | +8.21% | +3.97% | -15.48% | 152B | |
| -0.46% | -4.94% | -20.62% | +24.97% | 131B | |
| +1.73% | -1.21% | -52.56% | -1.77% | 72.26B | |
| -0.89% | -1.68% | -16.79% | -14.08% | 51.57B | |
| +0.41% | -0.12% | +12.38% | +19.30% | 52.38B | |
| +0.87% | +4.26% | +29.90% | +29.32% | 43.71B | |
| +0.90% | +3.29% | +38.63% | +51.60% | 40.72B | |
| +0.79% | +19.49% | +125.76% | +42.33% | 33.97B | |
| Average | +2.13% | +4.09% | +16.38% | +6.75% | 81.05B | |
| Weighted average by Cap. | +0.21% | +3.72% | +9.30% | +11.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 158M 136M 127M 116M 219M 15.08B 221M 1.5B 583M 7.61B 594M 581M 25.2B | 184M 158M 148M 135M 255M 17.54B 257M 1.74B 678M 8.85B 691M 676M 29.31B |
| Net income | -137M -117M -110M -101M -190M -13.07B -192M -1.3B -505M -6.59B -515M -504M -21.84B | -148M -127M -119M -108M -205M -14.1B -207M -1.4B -545M -7.11B -555M -543M -23.56B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/08/26 | $1.520 | +18.75% | 15,961,511 |
| 24/08/26 | $1.280 | -5.19% | 5,584,759 |
| 21/08/26 | $1.350 | +9.76% | 7,123,604 |
| 20/08/26 | $1.230 | -3.15% | 4,761,742 |
| 19/08/26 | $1.270 | +11.40% | 10,910,170 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PACB Stock
Select your edition
All financial news and data tailored to specific country editions
